No connection

Search Results

HXL

NEUTRAL
$92.3 Live
Hexcel Corporation · NYSE
Target $94.6 (+2.5%)
$47.5 52W Range $98.26

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 28, 2026
Market cap
$6.96B
P/E
61.13
ROE
8.4%
Profit margin
6.1%
Debt/Equity
0.79
Dividend yield
0.76%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
HXL presents a dichotomy between strong growth and extreme overvaluation. The deterministic health is mediocre with a Piotroski F-Score of 4/9, and the stock is trading at a severe premium, with the current price of $92.30 far exceeding both the Graham Number ($23.89) and the growth-based Intrinsic Value ($44.55). While earnings growth is robust at 40% YoY and liquidity is strong, the high P/E ratio and bearish insider sentiment suggest the current price has priced in far more than the fundamentals support. The divergence between recent price gains and a very low technical trend score (10/100) indicates a high risk of a correction.

Key Strengths

Strong earnings growth (40% YoY)
Robust short-term liquidity (Current Ratio 2.45)
Consistent track record of earnings beats over the last 25 quarters
Positive analyst consensus with a 'Buy' recommendation
Strong 1-year price momentum (+84.6%)

Key Risks

Extreme valuation gap (Price is >2x Intrinsic Value)
Very high trailing P/E ratio of 61.13
Low Return on Equity (ROE) of 8.41%
Bearish insider sentiment with net selling activity
Thin net profit margins (6.07%)
AI Fair Value Estimate
Based on comprehensive analysis
$46.5
-49.6% below current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
51
Moderate
Value
20
Future
80
Past
65
Health
50
Dividend
40
AI Verdict
Overvalued Growth
Key drivers: Massive valuation premium, Strong EPS growth, Mediocre financial health score
Confidence
90%
Value
20/100

Ref P/E 61.13, PEG 1.35, Graham Number $23.89

Positives
  • Forward P/E (29.04) is significantly lower than trailing P/E
Watchpoints
  • Price is 3.8x the Graham Number
  • Price is 2x the Intrinsic Value
  • P/B ratio of 5.50 is high
Future
80/100

Ref Growth rates

Positives
  • 40% YoY Earnings Growth
  • 28.7% Q/Q Earnings Growth
  • Positive revenue growth trend
Watchpoints
  • Recent Q/Q EPS growth dipped slightly (-5.8%)
Past
65/100

Ref Historical trends

Positives
  • Strong 1-year price performance
  • Consistent history of beating analyst estimates
Watchpoints
  • Historical volatility in earnings surprises
Health
50/100

Ref Piotroski F-Score 4/9

Positives
  • Strong Current Ratio (2.45)
  • Manageable Debt/Equity (0.79)
Watchpoints
  • Piotroski F-Score of 4/9 is only 'Stable', not 'Strong'
Dividend
40/100

Ref Yield 0.76%, Payout 45.7%

Positives
  • Sustainable payout ratio (45.7%)
Watchpoints
  • Very low dividend yield (0.76%)

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$92.3
Analyst Target
$94.6
Upside/Downside
+2.5%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for HXL and closest competitors.

Updated 2026-04-27
HXL
Hexcel Corporation
Primary
5Y
+69.5%
3Y
+31.7%
1Y
+84.6%
6M
+25.6%
1M
+16.3%
1W
+3.1%
ECG
Everus Construction Group, Inc.
Peer
5Y
+177.7%
3Y
+177.7%
1Y
+232.1%
6M
+44.9%
1M
+10.4%
1W
+5.6%
FLR
Fluor Corporation
Peer
5Y
+114.9%
3Y
+67.2%
1Y
+35.5%
6M
-1.5%
1M
+0.6%
1W
-0.7%
GAT
GATX Corporation
Peer
5Y
+123.6%
3Y
+78.6%
1Y
+39.5%
6M
+23.8%
1M
+16.5%
1W
-0.2%
FSS
Federal Signal Corporation
Peer
5Y
+190.9%
3Y
+131.3%
1Y
+52.0%
6M
-7.2%
1M
+4.2%
1W
+1.6%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
61.13
Forward P/E
29.04
PEG Ratio
1.35
P/B Ratio
5.5
P/S Ratio
3.59
EV/Revenue
4.08
EV/EBITDA
22.92
Market Cap
$6.96B

Profitability

Profit margins and return metrics

Profit Margin 6.07%
Operating Margin 12.58%
Gross Margin 24.09%
ROE 8.41%
ROA 5.04%

Growth

Revenue and earnings growth rates

Revenue Growth +9.9%
Earnings Growth +40.0%
Q/Q Revenue Growth +9.86%
Q/Q Earnings Growth +28.7%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.79
Moderate
Current Ratio
2.45
Strong
Quick Ratio
1.23
Good
Cash/Share
$0.72

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q1 2026

Revenue
$0.5B
Gross Margin
26.9%
Op. Margin
11.5%
Net Margin
7.4%
Total Assets
$2.7B
Liabilities
$1.5B
Equity
$1.3B
Debt/Equity
1.15x
Operating CF
$0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
-33%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-07-23
$N/A
2026-04-22
$0.49
+13.7% surprise
2026-01-28
$0.52
+5.2% surprise
2025-10-22
$0.37
-2.3% surprise

Industrials Sector Comparison

Comparing HXL against 469 companies in the Industrials sector (39 bullish, 174 neutral, 256 bearish)
P/E Ratio
61.13
This Stock
vs
98.24
Sector Avg
-37.8% (Discount)
Return on Equity (ROE)
8.41%
This Stock
vs
-19.38%
Sector Avg
-143.4% (Below Avg)
Profit Margin
6.07%
This Stock
vs
6.65%
Sector Avg
-8.8% (Weaker)
Debt to Equity
0.79
This Stock
vs
2.63
Sector Avg
-70.1% (Less Debt)
Revenue Growth
9.9%
This Stock
vs
71.29%
Sector Avg
-86.1% (Slower)
Current Ratio
2.45
This Stock
vs
3.09
Sector Avg
-20.6% (Weaker)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

LI DAVID H
Director
Stock Award
2026-04-02
457 shares
FITZSIMONS GINA
Officer
Option Exercise
2026-03-05
6,534 shares · $254,434
EVANS AMY S.
Officer
Sell
2026-02-27
1,500 shares · $139,200
STANAGE NICKIE LEE
Director
Option Exercise
2026-02-12
61,204 shares · $3,090,802
EVANS AMY S.
Officer
Stock Award
2026-01-30
583 shares
FITZSIMONS GINA
Officer
Stock Award
2026-01-30
1,035 shares
SMITH LYNDON JOHN
Officer
Stock Award
2026-01-30
598 shares
LEHMAN GAIL E
Officer
Stock Award
2026-01-30
2,001 shares
LEHMAN GAIL E
Officer
Stock Award
2026-01-30
2,001 shares
MERLOT THIERRY PHILIPP
Officer
Stock Award
2026-01-30
2,331 shares
EVANS AMY S.
Officer
Stock Award
2026-01-27
324 shares
FITZSIMONS GINA
Officer
Stock Award
2026-01-27
614 shares
SMITH LYNDON JOHN
Officer
Stock Award
2026-01-27
369 shares
LEHMAN GAIL E
Officer
Stock Award
2026-01-27
1,129 shares
STANAGE NICKIE LEE
Director
Stock Award
2026-01-21
20,063 shares
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-22

HXL filed an 8-K on April 22, 2026, likely to announce its first-quarter financial results.

10-Q
10-Q
2026-04-22

HXL submitted its 10-Q filing on April 22, 2026. The provided excerpts do not contain specific financial highlights or detailed risk factors.

8-K
8-K
2026-04-01

HXL filed an 8-K on April 1, 2026, likely to report its quarterly financial results.

DEF 14A
DEF 14A
2026-04-01

HXL filed a definitive proxy statement (DEF 14A) on April 1, 2026, providing shareholders with necessary information to vote on corporate matters at the upcoming annual meeting.

8-K
8-K
2026-03-13

HXL filed an 8-K on March 13, 2026, likely reporting its annual financial results for the preceding fiscal year.

8-K
8-K
2026-03-04
10-K
10-K
2026-02-11

HXL filed its annual 10-K report on February 11, 2026. Specific financial highlights and risk factors were not provided in the available metadata.

8-K
8-K
2026-01-28

HXL filed an 8-K on January 28, 2026, likely to report its fourth-quarter and full-year financial results.

8-K
8-K
2025-11-17

HXL filed a Form 8-K on November 17, 2025, likely to announce its third-quarter financial results.

8-K
8-K
2025-11-10
8-K
8-K
2025-10-23
8-K
8-K
2025-10-22
10-Q
10-Q
2025-10-22
8-K
8-K
2025-10-22
10-Q
10-Q
2025-07-24
Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
BUY
15 analysts
BMO Capital
2026-04-24
Maintains
Market Perform Market Perform
Jefferies
2026-04-06
Maintains
Hold Hold
Wells Fargo
2026-04-01
init
Overweight
B of A Securities
2026-02-12
up
Underperform Neutral
Jefferies
2026-02-02
Maintains
Hold Hold
Morgan Stanley
2026-01-30
up
Underweight Equal-Weight
RBC Capital
2026-01-30
Maintains
Outperform Outperform
Goldman Sachs
2026-01-20
Maintains
Neutral Neutral
UBS
2026-01-15
Maintains
Buy Buy

Past News Coverage

Recent headlines mentioning HXL from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile